188 related articles for article (PubMed ID: 31375149)
1. Requirement of the transcription factor YB-1 for maintaining the stemness of cancer stem cells and reverting differentiated cancer cells into cancer stem cells.
Yang F; Cui P; Lu Y; Zhang X
Stem Cell Res Ther; 2019 Aug; 10(1):233. PubMed ID: 31375149
[TBL] [Abstract][Full Text] [Related]
2. YB-1 interplays with ERĪ± to regulate the stemness and differentiation of ER-positive breast cancer stem cells.
Yang F; Chen S; He S; Huo Q; Hu Y; Xie N
Theranostics; 2020; 10(8):3816-3832. PubMed ID: 32206124
[No Abstract] [Full Text] [Related]
3. FOLFOX Therapy Induces Feedback Upregulation of CD44v6 through YB-1 to Maintain Stemness in Colon Initiating Cells.
Ghatak S; Hascall VC; Markwald RR; Misra S
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33451103
[TBL] [Abstract][Full Text] [Related]
4. Shrimp miRNA suppresses the stemness of human cancer stem cells
Zhang S; Zhang X
FASEB J; 2019 Oct; 33(10):10767-10779. PubMed ID: 31284761
[TBL] [Abstract][Full Text] [Related]
5. Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways.
Wang L; Liu Y; Zhou Y; Wang J; Tu L; Sun Z; Wang X; Luo F
J Exp Clin Cancer Res; 2019 Feb; 38(1):93. PubMed ID: 30791957
[TBL] [Abstract][Full Text] [Related]
6. Targeting Frizzled-7 Decreases Stemness and Chemotherapeutic Resistance in Gastric Cancer Cells by Suppressing Myc Expression.
Cheng Y; Li L; Pan S; Jiang H; Jin H
Med Sci Monit; 2019 Nov; 25():8637-8644. PubMed ID: 31733054
[TBL] [Abstract][Full Text] [Related]
7. YB-1 regulates Sox2 to coordinately sustain stemness and tumorigenic properties in a phenotypically distinct subset of breast cancer cells.
Jung K; Wu F; Wang P; Ye X; Abdulkarim BS; Lai R
BMC Cancer; 2014 May; 14():328. PubMed ID: 24885403
[TBL] [Abstract][Full Text] [Related]
8. Knock out CD44 in reprogrammed liver cancer cell C3A increases CSCs stemness and promotes differentiation.
Han S; Guo J; Liu Y; Zhang Z; He Q; Li P; Zhang M; Sun H; Li R; Li Y; Zeng W; Liu J; Lian L; Gao Y; Shen L
Oncotarget; 2015 Dec; 6(42):44452-65. PubMed ID: 26540347
[TBL] [Abstract][Full Text] [Related]
9. Concomitant targeting of multiple key transcription factors effectively disrupts cancer stem cells enriched in side population of human pancreatic cancer cells.
Wang X; Liu Q; Hou B; Zhang W; Yan M; Jia H; Li H; Yan D; Zheng F; Ding W; Yi C; Hai Wang
PLoS One; 2013; 8(9):e73942. PubMed ID: 24040121
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA miR-590-5p inhibits breast cancer cell stemness and metastasis by targeting SOX2.
Zhou L; Zhao LC; Jiang N; Wang XL; Zhou XN; Luo XL; Ren J
Eur Rev Med Pharmacol Sci; 2017 Jan; 21(1):87-94. PubMed ID: 28121351
[TBL] [Abstract][Full Text] [Related]
11. Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma.
Xiao W; Gao Z; Duan Y; Yuan W; Ke Y
J Exp Clin Cancer Res; 2017 Mar; 36(1):41. PubMed ID: 28279221
[TBL] [Abstract][Full Text] [Related]
12. RNA Polymerase II-Associated Factor 1 Regulates Stem Cell Features of Pancreatic Cancer Cells, Independently of the PAF1 Complex, via Interactions With PHF5A and DDX3.
Karmakar S; Rauth S; Nallasamy P; Perumal N; Nimmakayala RK; Leon F; Gupta R; Barkeer S; Venkata RC; Raman V; Rachagani S; Ponnusamy MP; Batra SK
Gastroenterology; 2020 Nov; 159(5):1898-1915.e6. PubMed ID: 32781084
[TBL] [Abstract][Full Text] [Related]
13. TMPRSS4 promotes cancer stem-like properties in prostate cancer cells through upregulation of SOX2 by SLUG and TWIST1.
Lee Y; Yoon J; Ko D; Yu M; Lee S; Kim S
J Exp Clin Cancer Res; 2021 Nov; 40(1):372. PubMed ID: 34809669
[TBL] [Abstract][Full Text] [Related]
14. Requirement of transcription factor NME2 for the maintenance of the stemness of gastric cancer stem-like cells.
Qi Y; Wei J; Zhang X
Cell Death Dis; 2021 Oct; 12(10):924. PubMed ID: 34628473
[TBL] [Abstract][Full Text] [Related]
15. Berberine induces neuronal differentiation through inhibition of cancer stemness and epithelial-mesenchymal transition in neuroblastoma cells.
Naveen CR; Gaikwad S; Agrawal-Rajput R
Phytomedicine; 2016 Jun; 23(7):736-44. PubMed ID: 27235712
[TBL] [Abstract][Full Text] [Related]
16. CRISPR/Cas9-mediated knockout of PIM3 suppresses tumorigenesis and cancer cell stemness in human hepatoblastoma cells.
Marayati R; Stafman LL; Williams AP; Bownes LV; Quinn CH; Markert HR; Easlick JL; Stewart JE; Crossman DK; Mroczek-Musulman E; Beierle EA
Cancer Gene Ther; 2022 May; 29(5):558-572. PubMed ID: 33864024
[TBL] [Abstract][Full Text] [Related]
17. Stemness and inducing differentiation of small cell lung cancer NCI-H446 cells.
Zhang Z; Zhou Y; Qian H; Shao G; Lu X; Chen Q; Sun X; Chen D; Yin R; Zhu H; Shao Q; Xu W
Cell Death Dis; 2013 May; 4(5):e633. PubMed ID: 23681228
[TBL] [Abstract][Full Text] [Related]
18. Suppressing Dazl modulates tumorigenicity and stemness in human glioblastoma cells.
Zhang F; Liu R; Zhang H; Liu C; Liu C; Lu Y
BMC Cancer; 2020 Jul; 20(1):673. PubMed ID: 32682409
[TBL] [Abstract][Full Text] [Related]
19. Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties.
Leung EL; Fiscus RR; Tung JW; Tin VP; Cheng LC; Sihoe AD; Fink LM; Ma Y; Wong MP
PLoS One; 2010 Nov; 5(11):e14062. PubMed ID: 21124918
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional factor six2 promotes the competitive endogenous RNA network between CYP4Z1 and pseudogene CYP4Z2P responsible for maintaining the stemness of breast cancer cells.
Zheng L; Guo Q; Xiang C; Liu S; Jiang Y; Gao L; Ni H; Wang T; Zhao Q; Liu H; Xing Y; Wang Y; Li X; Xi T
J Hematol Oncol; 2019 Mar; 12(1):23. PubMed ID: 30832689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
